NCU Research Grants Awarded 2020

Principal investigator
Project Title Project workplace (principal investigator) Awarded amount (Euros)
Anna Bill-Axelson

SPCG-17: Prostate Cancer Active Surveillance Trigger Trial (PCASTT)Uppsala University65.000
Satu Mustjoki
Immunological monitoring of therapy response in chronic myeloid leukemia by the Nordic CML study group (NCMLSG)University of Helsinki 65.000
Karin Smedby
Life after Lymphoma – how can we individualize treatment and care to reduce complications and improve lymphoma survivorship in the Nordic countriesKarolinska Institutet 40.000
Martin Eklund
International multisite clinical validation of artificial intelligence assisted diagnosis and grading of prostate cancer in needle biopsiesKarolinska Institutet 50.000
Björn Nilsson
Genetic predisposition for multiple myeloma: clinical impact of recently identified risk variantsLund University 50.000
Jesper Lagergren
The risk of oesophageal and gastric cancer after eradication of Helicobacter pyloriKarolinska Institutet 60.000
Bo Terning Hansen
Risk factors for pre-cancer and cancer: Registry follow-up of a population-based cohort of 118.000 women surveyed in Denmark, Iceland, Norway and SwedenCancer Registry of Norway 40.000
Ahti Anttila
Comparing cervical cancer screening in the Nordic countries: Transition from cytology to HPV testingFinnish Cancer Registry/ Cancer Society of Finland 40.000
Jørgen Bjerggaard JensenNordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBC – NORTH-REG Dwell-Time Study Aarhus University 40.000
Henrik Falconer
Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trialKarolinska University Hospital 40.000
Karen-Lise Garm Spindler
NOAC 9 – A Phase III Randomized Nordic Anal Cancer Group Study on Circulating Tumor DNA guided Follow-Up Aarhus University Hospital 50.000
Mats Jerkeman
Mantle cell lymphoma – a comprehensive Nordic initiative to improve patient outcomeLund University 40.000
Hedvig Nordeng
Nordic Medications in Pregnancy and Childhood Cancer Study (NorMedPreCCS)University of Oslo 50.000
Jiong Li
Maternal autoimmune diseases during pregnancy and childhood cancer in the offspring: a cohort study of 8 million children in five Nordic countriesAarhus University 40.000
Niels Junker
A phase 2 study on dual blockade of the PD-1/L1 pathway and beta-adrenergic receptor in advanced Angiosarcoma and Undifferentiated Pleomorphic SarcomaHerlev Hospital 40.000
Cecilie Hveding Blimark
Treatment and survival in multiple myeloma in the Nordic countries collaborative registry studies within the Nordic Myeloma Study GroupSahlgrenska University Hospital 40.000
Total750.000

NCU Research Grants Awarded 2019

Principal investigatorProject TitleProject workplace (principal investigator)Awarded amount (Euros)
Asgeir Store Jakola Beyond Observed Lesion Diameter (BOLD) glioblastoma surgery: a Nordic randomized controlled trial Neurosurgery, Sahlgrenska University Hospital 50.000
Björn Nilsson Genetic predisposition for multiple myeloma: clinical impact of recently identified risk variants Department of Laboratory Medicine, Lund University 50.000
Henrik Falconer Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial Patient Area Pelvic Cancer, Theme Cancer, Karolinska University Hospital 59.000
Eero Pukkala New wave of joint Nordic studies on work and cancer Finnish Cancer Registry 50.000
Jesper Lagergren The risk of oesophageal and gastric cancer after eradication of Helicobacter pylori Molecular medicine and Surgery, Karolinska Institutet 60.000
Jennifer Harris Genetic Epidemiology and Familial Risk of Cross-Cancer Associations: A Nordic Twin Study III Health Data and Digitalization, The Norwegian Institute of Public Health 40.000
Jana de Boniface Survival and axillary recurrence after sentinel node-positive breast cancer without axillary lymph node dissection: the randomized SENOMAC trial Dept. of Molecular Medicine and Surgery, Karolinska Institutet 76.000
Satu Mustjoki Immunological monitoring of therapy response in chronic myeloid leukemia by the Nordic CML study group (NCMLSG) Hematology Research Unit, University of Helsinki 65.000
Sigurdur Yngvi Kristinsson Comorbidity in patients with multiple myeloma Faculty of Medicine, University of Iceland 40.000
Cecilie Hveding Blimark Treatment and survival in multiple myeloma in the Nordic countries; collaborative registry studies within the Nordic Myeloma Study Group Nordic Myeloma Study Group (NMSG), Real World Data Group within NMSG at Sahlgrenska University Hospital Gothenburg Sweden 40.000
Karin Smedby Life after Lymphoma – how can we individualize treatment and care to reduce complications and improve lymphoma survivorship in the Nordic countries Karolinska Instituttet, Medicine Solna 40.000
Ahti Anttila Comparing cervical cancer screening in the Nordic countries: Transition from cytology to HPV testing Mass Screening Registry, Finnish Cancer Registry/ Cancer Society of Finland 40.000
Mats Jerkeman Mantle cell lymphoma – a comprehensive Nordic initiative to improve patient outcome Oncology, Lund University 40.000
Bo Terning Hansen Risk factors for pre-cancer and cancer: Registry follow-up of a population-based cohort of 118.000 women surveyed in Denmark, Iceland, Norway and Sweden Department of Research, Cancer Registry of Norway 40.000
Kim Sverker Pettersson Nanoparticle aided glycovarian biomarkers for the early detection of epithelial ovarian cancer (3rd year application) Department of Biochemistry, Division of Biotechnology, University of Turku 60.000
Total750.000